Definitive Health Sees FY24 Revenue $63M-$65M Vs $65.77M Estimate
Portfolio Pulse from Benzinga Newsdesk
Definitive Health projects FY24 revenue to be between $63M-$65M, slightly below the $65.77M estimate. This forecast accounts for the acquisition of the Carevoyance product suite, expecting a 6-10% year-over-year increase. The company also anticipates adjusted operating income of $18M-$19M, adjusted EBITDA of $19.5M-$20.5M, and adjusted net income of $12M-$13M, with per share earnings of $0.07-$0.08.
February 28, 2024 | 9:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Definitive Health's FY24 revenue projection is slightly below estimates, but shows growth due to the Carevoyance acquisition. Adjusted earnings per share are expected to be $0.07-$0.08.
The slight miss in revenue forecast compared to estimates may cause some concern among investors, but the projected growth from the Carevoyance acquisition and the positive outlook on adjusted earnings per share could mitigate negative impacts. The company's clear guidance on revenue and earnings growth demonstrates confidence in its strategic direction, which could help maintain investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100